Nevirapine Resistance and Breast-Milk HIV Transmission: Effects of Single and Extended-Dose Nevirapine Prophylaxis in Subtype C HIV-Infected Infants
Anitha Moorthy, Amita Gupta, Ramesh Bhosale et al. · 2009
Read Nevirapine Resistance and Breast-Milk HIV Transmission: Effects of Single and Extended-Dose Nevirapine Prophylaxis in Subtype C HIV-Infected Infants by Anitha Moorthy, Amita Gupta, Ramesh Bhosale et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004096.txt.
Description
Anitha Moorthy, Amita Gupta, Ramesh Bhosale, and co-authors studied drug resistance in HIV-exposed infants in 2009. Daily nevirapine given to infants cuts HIV spread through breast milk. The SWEN trial in India compared single-dose with six-week extended dosing. Babies in the trial carried subtype C HIV when infected.
Their PLOS ONE article assessed nevirapine resistance in those infants. Protection that breeds resistant virus could limit later treatment options. Balancing transmission prevention against resistance is a central program question. The Indian data inform dosing policy for breastfeeding mothers with HIV. It appeared in PLOS ONE, and the full text is free for any reader to check.
Catalog record
| CREATOR | Anitha Moorthy, Amita Gupta, Ramesh Bhosale et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004096